WT1 and endometrial serous adenocarcinoma: Nonetheless, they included several genes with known functional roles in ovarian and/or endometrial cancers as well as the common immunohistochemical biomarker, WT1, that is used to distinguish ovarian serous and endometrial serous adenocarcinomas [6,29,31].